# K910432: Hapset Hydroxylapatite Bone Graft Plaster

- Pathway: 510(k) (Traditional)
- Applicant: Lifecore Biomedical, Inc.
- Decided: May 1, 1991 after 90 days
- Product code: LYC (Bone Grafting Material, Synthetic)
- Device class: 2
- Regulation: 21 CFR 872.3930
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
46 later devices descend from it; 5 cite it directly.
0 of 47 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K073070: Dio Biotite-H Implant System (2008), 16 descendants of its own
- K030682: Calcium Hydroxylapatite Implant, Icc and 0.5CC, Models 8038-3, 8037-3 (2003), 15 descendants of its own
- K961511: Hapset Hydroxylapatite Bone Graft Plaster (1996), 11 descendants of its own
- K112532: ET II Bio-SA Fixture System (2012), 10 descendants of its own
- K051951: Cerament Bone Void Filler (2005), 10 descendants of its own

Source page: https://510kreport.com/device/K910432
Methodology: https://510kreport.com/methodology